Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06418243

Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors

This study's purpose is the comparison of the automatically segmented 3D model to the reference manual segmentation, based on the Dice precision index. It is implemented by making parents' patients, surgeons and surgical helpers answer specific questions comparing 3D images to usual 2D images of the patient's tumor.

Recruiting

Interested in participating?

Request Info

Key information

Age range

3 month–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The investigator will inform the child and his parents during the pre-surgical consultation, and will collect their non-opposition to be included in the study at the latest on the day of the MRI examination or CT scan. Patients requiring emergency imaging will not be included.

Pelvic tumors will benefit from MRI imaging and renal tumors from MRI and/or CT scan.

A CT scan will be carried out for retroperitoneal tumors other than renal tumors (mainly neuroblastomas).

All of the above examinations are carried out as part of the usual treatment, in the month preceding the surgery.

Pre-operatively After the imaging has been carried out, the 2D images will be presented to the patient and his family before surgery as it is done routinely. The 3D image will be showed afterwards. The family will have the opportunity to ask questions which the surgeon will answer as usually done.

The specific questionnaire will be completed by the patient and his family at the end of the consultation and given to the research team.

Once the patient is included and the examinations have been carried out, the operating surgeons and their assistants (help No. 1 and 2) will look at the 2D images, followed by the 3D images secondly a few days before surgery. They will complete the specific questionnaire and give it to the research team.

Once the patient is included and the imaging examinations have been carried out, surgeons external to the service will be contacted by the research team to organize a remote review session. The 2D images will be presented to them first, followed by the 3D images on the visualization software, via a remote communication system with screen sharing. They will complete the specific questionnaire independently and a copy of the questionnaires will then be sent to the research team by email and the originals sent by post.

Intraoperatively:

The 3D model of the patient will be displayed in the operating room, and/or integrated into the robot's display console (for robot-assisted surgeries) during the surgical procedure. At the end of the surgery, the operating surgeon and his assistants will complete (independently) a questionnaire on the consistency of the 2D and 3D images with the anatomy identified during the procedure and on the help or not provided by the 3D model.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children:

  • Children between 3 months and less than 18 years old
  • Children with a pelvic tumor requiring an MRI for a possible surgical intervention
  • Children with a retroperitoneal tumor requiring a CT scan or MRI with a view to surgical intervention
  • Children with no contraindication for a CT scan and/or 3T MRI
  • Children whose parents do not object to their participation in the study

Other participants:

  • Operating surgeon agreeing to participate in the study
  • Caregiver agreeing to participate in the study
  • External surgeon agreeing to participate in the study

Exclusion criteria

Children :

  • Contraindication to MRI: metallic ocular foreign body, pacemaker, mechanical heart valve, old vascular clips on cerebral aneurysm
  • Need for an MRI under general anaesthesia
  • Contraindication for a CT scan with injection: renal failure, allergy to iodinated contrast products
  • Patients having participated in a therapeutic clinical trial involving a new molecule within 30 days before inclusion
  • Emergency situation

Treatment and study plan

Primary outcomes

  1. Segmentation comparison

    Time frame: 1 month

    Comparison of the automatically segmented 3D model to the reference manual segmentation, based on the Dice precision index

Secondary outcomes

  1. Distance comparison

    Time frame: 1 month

    Distance comparison between the reference segmentation and the one obtained by the algorithm using the Hausdorff spacing.

  2. Anatomical structure recognition comparison

    Time frame: Day 0

    Recognition of anatomical structures comparison from 2D imaging and 3D imaging from score 1/score 3 of the pré-operative questionnaire for operating or external surgeons

  3. Pre-operative planning contribution

    Time frame: Day 0

    Contribution of 3D modeling comparison to 2D imaging in pre-operative planning from score 2/score 4 of the pre-operative questionnaire for operating or external surgeons

  4. Added value evaluation

    Time frame: Day 0

    Added value evaluation of 3D modelling compared to 2D imaging by using score 5 of the pre-operative questionnaire for operating or external surgeons

  5. Surgeons' support evaluation in pre-operative routine

    Time frame: Day 0

    Surgeons' support evaluation for integrating 3D modelling into routine pre-operative planning from score 6 of the pre-operative questionnaire for operating or external surgeons

  6. 2D imaging evaluation contribution for families' understanding

    Time frame: Day 0

    Evaluation of the contribution of 3D modelling for families in understanding the information (pathology and surgery) delivered by the surgeon to parents pre-operatively from score 1 of the family questionnaire

  7. 3D modelling evaluation contribution for families' understanding

    Time frame: Day 0

    Evaluation of the contribution of 3D modelling for families in understanding the information (pathology and surgery) delivered by the surgeon to parents pre-operatively from score 2 of the family questionnaire

  8. 3D modelling added value evaluation pre-operatively

    Time frame: Day 0

    Added value evaluation of 3D modelling compared to 2D imaging for families pre-operatively from score 3 of the family questionnaire

  9. 3D modelling added value evaluation during surgery

    Time frame: 1 month

    Contribution of 3D modelling evaluation compared to 2D imaging for surgeons during surgery from score 1 of the post-operative questionnaire for operating surgeons and their helpers

  10. Consistency evaluation between 3D modelling and anatomy

    Time frame: 1 month

    Consistency evaluation of the 3D imaging with anatomy observed intraoperatively from score 2 of the post-operative questionnaire for operating surgeons and their helpers

  11. Surgeons' support evaluation in current practice

    Time frame: 1 month

    Surgeons' support evaluation for integrating 3D modeling into their current practice from score 3 of the post-operative questionnaire for operating surgeons and their helpers

Study contacts

Contact information is provided by the study sponsor or research team.

Gael PLASTOW

CONTACT

[email protected]

+33 1 44 38 18 57

Thomas BLANC, MD

CONTACT

[email protected]

+33 1 44 49 41 53

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • Imagine Institute
  • Ligue contre le cancer, France
  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Non-interventional Study on the Contribution of 3D Modelling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors Compared to 2D Imaging

Acronym: 3D-PEDSURG

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 17, 2024
Registry last updated
Mar 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.